Art

J-GLOBAL ID：201802283853599258   Reference number：18A0052864

Comprehensive analyses using next-generation sequencing and immunohistochemistry enable precise treatment in advanced gastric cancer

次世代シーケンシングと免疫組織化学を用いた包括的な解析は進行胃癌における精密な治療を可能とする

Author (13)： KUBOKI Y. (National Cancer Center Hospital East, Chiba) ,  KUBOKI Y. (National Cancer Center, Chiba) ,  KUBOKI Y. (Keio Univ., Tokyo) ,  YAMASHITA S. (National Cancer Center Res. Inst., Tokyo, JPN) ,  NIWA T. (National Cancer Center Res. Inst., Tokyo, JPN) ,  USHIJIMA T. (National Cancer Center Res. Inst., Tokyo, JPN) ,  NAGATSUMA A. (National Cancer Center, Chiba) ,  KUWATA T. (National Cancer Center, Chiba) ,  YOSHINO T. (National Cancer Center Hospital East, Chiba) ,  DOI T. (National Cancer Center Hospital East, Chiba) ,  OCHIAI A. (National Cancer Center, Chiba) ,  OCHIAI A. (Keio Univ., Tokyo) ,  OHTSU A. (National Cancer Center, Chiba)
Material： Annals of Oncology  (Ann Oncol)
Volume： 27  Issue： 1  Page： 127-133  Publication year： Jan. 2016 
JST Material Number： W0107A  ISSN： 0923-7534  CODEN： ANONE2  Document type： Article
Article type： 原著論文  Country of issue： United Kingdom (GBR)  Language： ENGLISH (EN)

Thesaurus term： human(primates) ,...
Semi thesaurus term： *Progressive gastric carcinoma ,...

Register(free) or Log In to access     To see more with JDream III (charged).   {{ this.onShowAbsJLink("http://jdream3.com/lp/jglobal/index.html?docNo=18A0052864&from=J-GLOBAL&jstjournalNo=W0107A") }}

JST classification (1)： Tumors(=neoplasms)of digestive system  (GH04000D)

Reference (26)：

• Bang Y, Van Cutsem E, Feyereislova A et al. Trastuzumab in combination with chemotherapy versus chemotherapy alone for treatment of HER2-positive advanced gastric or gastro-oesophageal junction cancer (ToGA): a phase 3, open-label, randomised controlled trial. Lancet 2010; 376: 687-697.
• Wilke H, Muro K, Van Cutsem E et al. Ramucirumab plus paclitaxel versus placebo plus paclitaxel in patients with previously treated advanced gastric or gastro-oesophageal junction adenocarcinoma (RAINBOW): a double-blind, randomised phase 3 trial. Lancet Oncol 2014; 15(11): 1224-1235.
• Fuchs CS, Tomasek J, Yong CJ et al. Ramucirumab monotherapy for previously treated advanced gastric or gastro-oesophageal junction adenocarcinoma (REGARD): an international, randomised, multicentre, placebo-controlled, phase 3 trial. Lancet 2014; 383: 31-39.
• Li J, Qin S, Xu J et al. Apatinib for chemotherapy-refractory advanced metastatic gastric cancer: results from a randomized, placebo-controlled, parallel-arm, phase II trial. J Clin Oncol 2013; 31: 3219-3925.
• Ohtsu A, Shah M, Van Cutsem E et al. Bevacizumab in combination with chemotherapy as first-line therapy in advanced gastric cancer: a randomized, double-blind, placebo-controlled phase III study. J Clin Oncol 2011; 29: 3968-3976.

Terms in the title (5)： 次世代シーケンシング ,  免疫組織化学 ,  解析 ,  進行胃癌 ,  治療